Skip to main content
. 2021 Aug 6;149(10):1732–1743. doi: 10.1002/ijc.33727

FIGURE 3.

FIGURE 3

Emerging technologies for identifying improved patient‐specific treatments, illustrations of (A) CRISPR screening for identification of synthetic lethalities, (B) single‐cell technologies to identify cancer‐specific epigenetic/transcriptional changes and (C) patient‐specific organoid modeling as a basis for personalized drug screening and therapeutic discovery